Studentu komanda no R\u012bgas Stradi\u0146a universit\u0101tes (RSU) VitaEase novembra izska\u0146\u0101 p\u0101rst\u0101v\u0113ja Latviju Eiropas Inov\u0101ciju un tehnolo\u0123iju instit\u016bta (EIT) organiz\u0113taj\u0101 i-Days jeb inov\u0101ciju dienu Eiropas fin\u0101l\u0101, kur izc\u012bn\u012bja l\u012bdz \u0161im augst\u0101ko nov\u0113rt\u0113jumu \u2013 otro vietu 23 komandu konkurenc\u0113.<\/p>\n
i-Days fin\u0101l\u0101 VitaEase prezent\u0113ja ideju par sensoru, kas apr\u012bkots ar mikroadatu un, savienojum\u0101 ar pacienta viedier\u012bci, pal\u012bdz\u0113tu re\u0101llaik\u0101 uzraudz\u012bt sirdsdarb\u012bbu un citus b\u016btiskus r\u0101d\u012bt\u0101jus p\u0113c sirds oper\u0101cij\u0101m vai vesel\u012bbas sare\u017e\u0123\u012bjumiem. VitaEase komand\u0101 ir tr\u012bs RSU medic\u012bnas studenti \u2013 E\u0161ans Skidars (Eshaan Skidar), K\u0113rtija Taniru (Keerthi Tanniru) un Hiba Agata Alhaja (Hiba Agata Alhaj).<\/p>\n
Komanda savu inov\u0101ciju ce\u013cu s\u0101ka EIT Health Latvijas i-Days hakaton\u0101, kur vair\u0101k nek\u0101 desmit komandu konkurenc\u0113 uzvar\u0113ja, sa\u0146emot naudas balvu no hakatona atbalst\u012bt\u0101ja Roche un ce\u013caz\u012bmi uz i-Days fin\u0101lu Par\u012bz\u0113. VitaEase uzsver, ka, lai gan tirg\u016b jau ir pieejamas da\u017e\u0101das viedier\u012bces vesel\u012bbas r\u0101d\u012bt\u0101ju uzraudz\u012bbai, \u0161obr\u012bd neviena nepied\u0101v\u0101 nep\u0101rtrauktu biomar\u0137ieru monitoringu asin\u012bs.<\/p>\n
Risin\u0101juma att\u012bst\u012bb\u0101 pl\u0101nots izmantot ar\u012b m\u0101ksl\u012bgo intelektu, kas agr\u012bni sp\u0113tu br\u012bdin\u0101t par potenci\u0101lajiem iekaisumiem, infekcij\u0101m vai citiem vesel\u012bbas riskiem. i-Days fin\u0101l\u0101 Francijas galvaspils\u0113t\u0101 Par\u012bz\u0113 tik\u0101s 23 nacion\u0101lo i-Days hakatonu uzvar\u0113t\u0101ju komandas no da\u017e\u0101d\u0101m Eiropas valst\u012bm.<\/p>\n
\u017d\u016brija v\u0113rt\u0113ja komandas p\u0113c vair\u0101kiem krit\u0113rijiem, tostarp sp\u0113jas izprast vesel\u012bbas apr\u016bpes probl\u0113mas, risin\u0101juma inov\u0101ciju l\u012bme\u0146a, dizaina un prezent\u0101cijas kvalit\u0101tes. VitaEase apbalvota ar sudraba meda\u013cu, savuk\u0101rt pirm\u0101 vieta pie\u0161\u0137irta komandai no Sp\u0101nijas.<\/p>\n
\u201cGatavojoties fin\u0101lam, str\u0101d\u0101j\u0101m pie savas idejas, p\u0101rdom\u0101j\u0101m t\u0101s zin\u0101tnisko pamatojumu un kritiski izv\u0113rt\u0113j\u0101m, cik realiz\u0113jams tas paties\u012bb\u0101 ir. Tas bija izaicin\u0101jums, par kuru esmu pateic\u012bgs un v\u0113rt\u012bga m\u0101c\u012bba iniciat\u012bv\u0101, atbild\u012bb\u0101 un j\u0113gpiln\u0101 darb\u0101. Sav\u0101 medic\u012bnas karjer\u0101 esmu tikai s\u0101kuma posm\u0101, t\u0101d\u0113\u013c ir liels pagodin\u0101jums, ka m\u016bsu komanda tika atz\u012bta Eiropas l\u012bmen\u012b,\u201d dal\u0101s VitaEase p\u0101rst\u0101vis E\u0161ans Skidars.<\/p>\n
i-Days fin\u0101ls ik gadu pulc\u0113 i-Days uzvar\u0113t\u0101jus, EIT programmu absolventus, inov\u0101ciju nomet\u0146u komandas un topo\u0161os novatorus no visas Eiropas. Pas\u0101kuma m\u0113r\u0137is ir iedvesmot jaunos speci\u0101listus, atz\u012bm\u0113t vi\u0146u sasniegumus un dot praktisku impulsu t\u0101l\u0101kai izaugsmei vesel\u012bbas apr\u016bpes inov\u0101ciju jom\u0101.<\/p>\n
Divu dienu laik\u0101 dal\u012bbnieki apmekl\u0113 meistarklases, lekcijas un darbn\u012bcas, kas v\u0113rstas uz prasmju stiprin\u0101\u0161anu un jaunu sadarb\u012bbu veido\u0161anu, lai pal\u012bdz\u0113tu vi\u0146iem tuvoties risin\u0101jumiem, kas var\u0113tu uzlabot vesel\u012bbas apr\u016bpi Eirop\u0101.<\/p>\n
EIT Health ir Eiropas publisk\u0101 un priv\u0101t\u0101 sektora t\u012bklojums vesel\u012bbas apr\u016bpes jom\u0101, kuru izveidoju\u0161i vair\u0101k nek\u0101 150 partneru \u2013 Eiropas vado\u0161ie uz\u0146\u0113mumi, universit\u0101tes, p\u0113tniec\u012bbas un att\u012bst\u012bbas centri, k\u0101 ar\u012b slimn\u012bcas un instit\u016bti. T\u012bklojuma uzdevums ir nodro\u0161in\u0101t t\u0101du vesel\u012bbas apr\u016bpi, kas n\u0101kotn\u0113 sniegs Eiropas iedz\u012bvot\u0101jiem iesp\u0113ju dz\u012bvot ilg\u0101k un vesel\u012bg\u0101k.<\/p>\n
EIT Health Latvijas centrs (EIT Health RIS Hub in Latvia) kop\u0161 2019. gada atrodas R\u012bgas Stradi\u0146a universit\u0101t\u0113.<\/p>\n
i-Days pied\u0101v\u0101 iesp\u0113ju studentiem, rezidentiem un jaunajiem profesion\u0101\u013ciem piedal\u012bties inovat\u012bvu vesel\u012bbas apr\u016bpes ideju izstr\u0101d\u0113 da\u017e\u0101dos EIT Health pas\u0101kumos vis\u0101 Eirop\u0101. Pas\u0101kumu laik\u0101 dal\u012bbnieki g\u016bst padzi\u013cin\u0101tu ieskatu vesel\u012bbas apr\u016bpes jaut\u0101jumos, iepaz\u012bstas ar jaun\u0101kaj\u0101m inov\u0101cij\u0101m vesel\u012bbas nozar\u0113 un sacen\u0161as komand\u0101s, lai risin\u0101tu re\u0101l\u0101s dz\u012bves probl\u0113mas. Katras valsts i-Days uzvar\u0113t\u0101jkomanda ieg\u016bst galveno balvu \u2013 ce\u013caz\u012bmi uz i-Days Eiropas konkursa fin\u0101lu, kas \u0161ogad norisin\u0101sies Francijas galvaspils\u0113t\u0101 Par\u012bz\u0113.<\/p>\n
Skat\u012bties p\u0101r\u0113jos att\u0113lus<\/p>\n","protected":false},"excerpt":{"rendered":"Studentu komanda no R\u012bgas Stradi\u0146a universit\u0101tes (RSU) VitaEase novembra izska\u0146\u0101 p\u0101rst\u0101v\u0113ja Latviju Eiropas Inov\u0101ciju un tehnolo\u0123iju instit\u016bta (EIT)…\n","protected":false},"author":2,"featured_media":66098,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[869,77,870,76,867,35,39,38,36,37,34,871,868,40,21],"class_list":{"0":"post-66097","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bizness","8":"tag-biznesa-zinas","9":"tag-bizness","10":"tag-bizness-latvija","11":"tag-business","12":"tag-dienas-zinas","13":"tag-latvia","14":"tag-latvian","15":"tag-latviesu","16":"tag-latviesu-valoda","17":"tag-latviesuvaloda","18":"tag-latvija","19":"tag-latvijas-biznesa-zinas","20":"tag-latvijas-zinas","21":"tag-lv","22":"tag-zinas"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115665678094206370","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/66097","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=66097"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/66097\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/66098"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=66097"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=66097"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=66097"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}